• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS PARIETEX; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS PARIETEX; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number TECR1510
Device Problems Loss of or Failure to Bond (1068); Migration or Expulsion of Device (1395); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problems Bacterial Infection (1735); Purulent Discharge (1812); Fistula (1862); Unspecified Infection (1930); Pain (1994); Staphylococcus Aureus (2058); Scar Tissue (2060); Discharge (2225); Hernia (2240); Injury (2348); Fluid Discharge (2686); No Code Available (3191); Unspecified Tissue Injury (4559)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment.It was reported that after a procedure where this device was implanted, the patient experienced unincorporated mesh, infected mesh.After the original procedure, additional potentially related procedures were performed, including removal of mesh.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of ventral incisional hernia.It was reported that after implant, the patient experienced recurrence, mesh not incorporated, infection, (b)(6), cavity that was subfascial where the mesh was contained seropurulent fluid, granulation tissue, draining fistula, mesh migration, pain, and scarring.Post-operative patient treatment included revision surgery, excision of mesh, repair of hernia with allomax mesh, component separation, elliptical incision made along the entire anterior abdominal wall midline cicatrix, wound vac, and dissection carried through the subcutaneous tissue utilizing electrocautery.
 
Manufacturer Narrative
This information was received as a part of an extensive mesh litigation submission to medtronic.The fda was notified of this large complaint receipt.Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of ventral incisional hernia.It was reported that after implant, the patient experienced recurrence, mesh not incorporated, infection, mrsa, cavity that was subfascial where the mesh was contained seropurulent fluid, granulation tissue, draining fistula, mesh migration.Post-operative patient treatment included revision surgery, excision of mesh, repair of hernia with allomax mesh, component separation, elliptical incision made along the entire anterior abdominal wall midline cicatrix, dissection carried through the subcutaneous tissue utilizing electrocautery.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of ventral incisional hernia.It was reported that after implant, the patient experienced recurrence, mesh not incorporated, infection, cavity that was subfascial where the mesh was contained seropurulent fluid, granulation tissue, draining fistula, mesh migration.Post-operative patient treatment included revision surgery, excision of mesh, repair of hernia with allomax mesh, component separation, elliptical incision made along the entire anterior abdominal wall midline cicatrix, dissection carried through the subcutaneous tissue utilizing electrocautery.
 
Manufacturer Narrative
This information was received as a part of an extensive mesh litigation submission to medtronic.The fda was notified of this large complaint receipt.Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.Additional information: weight, describe event or problem, other relevant history, if explanted, give date, initial reporter (email), date received by mfr, event problem and evaluation codes.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PARIETEX
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
tracy landers
5920 longbow drive
boulder,co, CT 80301
3035816943
MDR Report Key7495282
MDR Text Key107628412
Report Number9615742-2018-01075
Device Sequence Number1
Product Code FTL
UDI-Device Identifier10884521180284
UDI-Public10884521180284
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K982532
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup,Followup
Report Date 01/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/08/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/30/2013
Device Model NumberTECR1510
Device Catalogue NumberTECR1510
Device Lot NumberSID00288
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/15/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
TECR1510(LOT#: SIH00275)
Patient Outcome(s) Required Intervention;
Patient Age39 YR
Patient SexFemale
Patient Weight117 KG
-
-